Meloxicam Market Trends

  • Report ID: 5360
  • Published Date: Nov 26, 2025
  • Report Format: PDF, PPT

Meloxicam Market - Growth Drivers and Challenges

Growth Drivers

  • Increasing Technological Advancement – The growth of this meloxicam market can be ascribed to an increasing technological advancement taking place in meloxicam. The global growth rate of the meloxicam retail market has been accelerated by the launch of new and enhanced goods as a result of the development of fresh technologies. Furthermore, advancements in drug delivery technologies and formulations are enhancing the efficacy and safety of meloxicam making it a more appealing treatment option.
  • Increasing Prevalence of NSAIDs - Increased preference for NSAIDs over other painkillers like opioids also contributes to the meloxicam market's expansion in the anticipated time period. NSAIDs such as meloxicam are at times preferred over other painkillers such as opioids owing to their lower risk of addiction and side effects. In addition, the meloxicam market is growing as chronic inflammation and pain illnesses become more prevalent.
  • Growing Strategic Collaboration and Partnerships – Pharmaceutical companies are collaborating with research institutions and other companies to develop new formulations and applications for meloxicam. Therefore, this is accelerating the market expansion of meloxicam in the upcoming time period. 

Challenges

  • Competition from other NSAIDs – Meloxicam is one of many NSAIDs on the market, and it faces stiff competition from other drugs in its class, such as ibuprofen and naproxen. These drugs are often less expensive than meloxicam and may have a better safety profile. Therefore, high competition by other NSAIDs is expected to hamper the meloxicam market growth of meloxicam in the forthcoming years.
  • Concerns Associated with Side Effects of Meloxicam is Predicted to Restrict the Market Expansion in the Future Times
  • The Availability of Generic Meloxicam is Posing a Limitation on the Market Expansion in Forecast Period.

Base Year

2025

Forecast Year

2026-2035

CAGR

4.8%

Base Year Market Size (2025)

USD 7.64 billion

Forecast Year Market Size (2035)

USD 12.21 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of meloxicam is evaluated at USD 7.97 billion.

The global meloxicam market size was worth over USD 7.64 billion in 2025 and is poised to grow at a CAGR of around 4.8%, reaching USD 12.21 billion revenue by 2035.

North America meloxicam market is expected to hold a 33% share, attributed to the growing incidence of arthritis and chronic pain disorders.

Key players in the market include Healthy Life Pharma Private Limited., EPICON LIFESCIENCES LLP, Boehringer Ingelheim GmbH., Baudax Bio, Heron Therapeutics Inc., Avanstra Inc., PD-Rx Pharmaceuticals, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos